TITLE

Adolescent immunisation: the next big thing?

AUTHOR(S)
Finn, Adam; Clarke, Ed; Mytton, Julie
PUB. DATE
June 2011
SOURCE
Archives of Disease in Childhood -- Fetal & Neonatal Edition;Jun2011, Vol. 96 Issue 6, p497
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
The author presents information on adolescent immunisation in Great Britain. The introduction of the human papillomavirus (HPV) vaccine into the routine immunisation schedule for girls in Great Britain has proven again the probability of total adolescent immunisation, assuming proper prior consultation and resource allocation.
ACCESSION #
60604929

 

Related Articles

  • Adolescent immunisation: the next big thing? Finn, Adam; Clarke, Ed; Mytton, Julie // Archives of Disease in Childhood -- Fetal & Neonatal Edition;Jun2011, Vol. 96 Issue 6, p497 

    The author presents information on adolescent immunisation in Great Britain. The introduction of the human papillomavirus (HPV) vaccine into the routine immunisation schedule for girls in Great Britain has proven again the probability of total adolescent immunisation, assuming proper prior...

  • Universal HPV vaccine coverage would be cost-effective.  // Contemporary Pediatrics;Sep2008, Vol. 25 Issue 9, p36 

    The article discusses research being done on the cost-effectiveness of universal vaccine coverage against human papillomavirus (HPV) for teenage girls in the U.S. It references a study published in the August 21, 2008 issue of "The New England Journal of Medicine." Researchers used computer...

  • Boys in US not taking up HPV vaccination.  // PharmacoEconomics & Outcomes News;5/1/2013, Issue 677, p4 

    The article discusses a research on human papillomavirus (HPV) vaccination in reference to a study "HPV vaccination among adolescent males: Result from the National Immunization Survey-Teen," by P.L. Reiter, et al, in the April 16, 2013 issue of "Vaccine."

  • HPV vaccination program extended.  // Medical Device Daily;12/31/2008, Vol. 12 Issue 232, p7 

    The article reports on the statement of British Public Health Minister Dawn Primarolo that more than 70% of 12- to 13-year-old girls have already had their first human papillomavirus (HPV) vaccination since the Great Britain campaign started in September 2008. As of December 2008, 148 of 152...

  • Parental attitudes and information needs in an adolescent HPV vaccination programme. Stretch, R.; Roberts, S. A.; McCann, R.; Baxter, D.; Chambers, G.; Kitchener, H.; Brabin, L. // British Journal of Cancer;12/2/2008, Vol. 99 Issue 11, p1908 

    We sent a questionnaire to 38% (1084) of 2817 parents whose daughters had been offered human papillomavirus vaccination and who had agreed to participate. Of these, 60% (651) returned a questionnaire. Responses suggested that fact sheets and parent information evenings confirmed, rather than...

  • Poor HPV vaccine uptake in adolescent girls in Hong Kong.  // PharmacoEconomics & Outcomes News;Nov2013, Issue 691, p8 

    The article reports on the results of a study in Hong Kong, China which unveil very low uptake of the human papillomavirus (HPV) vaccine amongst adolescent girls, and suggest the need for a school-based education and provision.

  • HPV Vaccines: Are We Ready to Protect Our Children? Saca-Hazboun, Hanan // ONS Connect;Oct2008, Vol. 23 Issue 10, p27 

    This article discusses growing controversy and questions from the public regarding the use of a human papillomavirus (HPV) vaccine in preteen girls in the U.S. It identifies several hurdles to HPV vaccination: the state mandate, the healthcare team, the parents and the religious community. It...

  • Even with vaccine mandates, widespread HPV vaccine use expected to take time.  // Hem/Onc Today;6/10/2009, Vol. 10 Issue 11, p59 

    The article reports on the claim by Amanda Dempsey of the Child Health Evaluation and Research Unit of Michigan and colleagues that it will probably take many years before a large percentage of adolescent girls in the U.S. are vaccinated with the human papillomavirus vaccine, during the 43rd...

  • Immunogenicity of Quadrivalent HPV Vaccine Among Girls 11 to 13 Years of Age Vaccinated Using Alternative Dosing Schedules: Results 29 to 32 Months After Third Dose. LaMontagne, D. Scott; Thiem, Vu Dinh; Huong, Vu Minh; Tang, Yuxiao; Neuzil, Kathleen M. // Journal of Infectious Diseases;Oct2013, Vol. 208 Issue 8, p1325 

    Background. Immune response to quadrivalent human papillomavirus (HPV) vaccine delivered at 0, 2, and 6 months in young adolescent females plateaus around 24 months after immunization. Antibody levels >24 months postvaccination using extended dosing schedules is unknown.Methods. We conducted a...

  • Socializing Sexual Risk. Jeffrey, Terence P. // Human Events;1/22/2007, Vol. 63 Issue 3, p5 

    The article focuses on issues arising from the proposed immunization of pre-teenage girls against the Human Papilloma Virus (HPV) in the U.S. The District of Columbia plans to consider a measure that would mandate such injections to girls enrolling in 6th grade. The Food and Drug Administration...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics